Alnylam Pharmaceuticals

RNA interference (RNAi) is a naturally occurring process of gene regulation that is already at work inside your body. RNAi therapeutics, which were pioneered by Alnylam, utilize this process to silence the genes that cause or contribute to disease. #ScienceCurious to learn more about #RNAi? Click here: https://bit.ly/3oR8r2l #RNAiTherapeutics #siRNA #GeneSilencing #RNA

HCPs: Conversations about family health history can help your patients understand inherited diseases, like hereditary #ATTR (#hATTR) #amyloidosis. Encourage your patients to discuss health conditions that run in their families to better understand their health. https://bit.ly/3QPohJd #hATTRoadTrip

Healthcare Professionals: With hereditary #ATTR (#hATTR), toxic misfolded TTR accumulates at multiple sites in the body, including the nerves, heart and digestive system, and ultimately causes symptoms of the disease. Because the deposition of toxic misfolded TTR can lead to irreversible damage, it is important that physicians take a comprehensive and rapid approach to disease management. Learn more about this inherited #RareDisease and an available treatment option for the polyneuropathy of hATTR in a new Alnylam-sponsored article in Healio: https://bit.ly/4f9H9fu #Amyloidosis

We’re working to transform medicine with RNAi therapeutics. By silencing disease-causing genes, we’re opening the door to new possibilities for conditions from rare disorders to neurodegenerative diseases. Read more about #RNAiTherapeutics in this Scientific American article: https://bit.ly/43A2ixe #siRNA #GeneSilencing #RNA (sponsored content; for U.S. audiences only)

Today, we celebrate the incredible women at Alnylam who inspire us every day with their talent, dedication, and leadership. We are proud to spotlight the diverse women who drive innovation, collaboration, and success within our team. #InternationalWomensDay #IWD2025 #WomenInScience

Healthcare Professionals: Hereditary #ATTR (#hATTR) is often misdiagnosed because symptoms can resemble those of other conditions. This can delay critical intervention as toxic misfolded TTR continues to accumulate in the body and cause disease progression. Read more in an Alnylam-sponsored Healio article: https://bit.ly/4f9H9fu #Amyloidois

U.S. Healthcare Professionals: Navigating a #RareDisease like primary #hyperoxaluria type 1 (PH1) takes a well-coordinated care team. In this article, pediatric nephrologist, Dr. Raymond Quigley, shares how collaboration among specialists can support accurate, timely diagnosis and highlights advancements in disease management that are supporting patient care. Additionally, learn more from Courtney, who discusses her son’s journey with this rare disease. Read the full story: https://bit.ly/49wLl7S

Today on Rare Disease Day, we shine a spotlight on the 300+ million people worldwide living with a #raredisease.   We asked members of the #porphyria, #hyperoxaluria and #amyloidosis communities, including patients, caregivers and advocacy group leaders, to share their hopes for the future of rare disease. Using generative AI, we developed a piece of art to bring these dreams to life in a world that is “More Than You Can Imagine.”   Thank you to EURORDIS-Rare Diseases Europe and National Organization for Rare Disorders for your unwavering commitment to making this imagined world a reality for all those impacted by a rare disease.

For #RareDiseaseDay, we are using generative AI to artistically depict a world that is “More Than You Can Imagine.” We asked members of the rare disease community to share their dreams for the future of rare disease.   Laura dreams of a future where her daughter, living with primary #hyperoxaluria type 1 (PH1), will be able to have children of her own if she chooses to. See Laura’s dream brought to life.   Rare Disease Day EURORDIS-Rare Diseases Europe National Organization for Rare Disorders

For Rare Disease Day, we asked members of the acute hepatic #porphyria (AHP) community to share their dreams for the future of rare disease.   Katri, who lives with AHP, wishes for happiness and stability. See her dream brought to life through generative AI to depict a world that is “More Than You Can Imagine.” #RareDiseaseDay   EURORDIS-Rare Diseases Europe National Organization for Rare Disorders